Inventor

GARACI ENRICO

IT14 patents

⚠️ This page may combine multiple inventors who share the name “GARACI ENRICO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCICLONE PHARMACEUTICALS INT LTD

2 patents

US11524056B2Dec 13, 2022

Thymosin alpha 1 for use in treatment of cystic fibrosis

SCICLONE PHARMACEUTICALS INT LTD1 citations69

US10478474B2Nov 19, 2019

Thymosin alpha 1 for use in treatment of cystic fibrosis

SCICLONE PHARMACEUTICALS INT LTD2 citations69

RASI GUIDO

2 patents

US8389680B2Mar 5, 2013

Treatment of Aspergillus infections with alpha thymosin peptides

RASI GUIDO0 citations41

US8207294B2Jun 26, 2012

Treatment of Aspergillus infections with alpha thymosin peptides

RASI GUIDO1 citations41

ALIENOR FARMA

1 patent

US10214591B1Feb 26, 2019

Monoclonal antibody to human line-1 ORF2 protein and method for early detection of transforming cells in pre-neoplastic tissues of a human subject

ALIENOR FARMA11 citations70

CONSIGLIO NAZIONALE RICERCHE

1 patent

US6180681B1Jan 30, 2001

2-cyclopenten-1-one as an inducer of HSP70

CONSIGLIO NAZIONALE RICERCHE12 citations68

GARACI ENRICO

1 patent

US8431617B2Apr 30, 2013

Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections

GARACI ENRICO5 citations61

SCICLONE PHARMACEUTICALS INT SG PTE LTD

1 patent

US12083165B2Sep 10, 2024

Thymosin alpha 1 for use in treatment of cystic fibrosis

SCICLONE PHARMACEUTICALS INT SG PTE LTD0 citations56

MIMETECH S R L

1 patent

US7625892B2Dec 1, 2009

Pharmaceutical compositions for the treatment of diseases related to neurotrophines

MIMETECH S R L2 citations50

SIGMA TAU IND FARMACEUTI

1 patent

US8022036B2Sep 20, 2011

Use of thymosin alpha 1 for the treatment of immunological diseases

SIGMA TAU IND FARMACEUTI0 citations48

SAVARINO ANDREA

1 patent

US8785493B2Jul 22, 2014

Treatment of retroviral reservoirs exploiting oxidative stress

SAVARINO ANDREA0 citations44

ROMANI LUIGINA

1 patent

US8337828B2Dec 25, 2012

Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection

ROMANI LUIGINA0 citations42

CASSONE ANTONIO

1 patent

US8445484B2May 21, 2013

Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases

CASSONE ANTONIO0 citations36

FAZIO VITO M

1 patent

US9150627B2Oct 6, 2015

Anti tumoral immunogenic peptides and vaccine thereof

FAZIO VITO M0 citations32